142 related articles for article (PubMed ID: 27936126)
1. The NS4A Cofactor Dependent Enhancement of HCV NS3 Protease Activity Correlates with a 4D Geometrical Measure of the Catalytic Triad Region.
Hamad HA; Thurston J; Teague T; Ackad E; Yousef MS
PLoS One; 2016; 11(12):e0168002. PubMed ID: 27936126
[TBL] [Abstract][Full Text] [Related]
2. Comparative molecular dynamics simulation of Hepatitis C Virus NS3/4A protease (Genotypes 1b, 3a and 4b) predicts conformational instability of the catalytic triad in drug resistant strains.
Kramer M; Halleran D; Rahman M; Iqbal M; Anwar MI; Sabet S; Ackad E; Yousef MS
PLoS One; 2014; 9(8):e104425. PubMed ID: 25111232
[TBL] [Abstract][Full Text] [Related]
3. A 3D structural model and dynamics of hepatitis C virus NS3/4A protease (genotype 4a, strain ED43) suggest conformational instability of the catalytic triad: implications in catalysis and drug resistivity.
Rimmert B; Sabet S; Ackad E; Yousef MS
J Biomol Struct Dyn; 2014; 32(6):950-8. PubMed ID: 23768174
[TBL] [Abstract][Full Text] [Related]
4. A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals.
Franco S; Clotet B; Martínez MA
Virus Res; 2008 Feb; 131(2):260-70. PubMed ID: 18037183
[TBL] [Abstract][Full Text] [Related]
5. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
McCoy MA; Senior MM; Gesell JJ; Ramanathan L; Wyss DF
J Mol Biol; 2001 Feb; 305(5):1099-110. PubMed ID: 11162117
[TBL] [Abstract][Full Text] [Related]
6. The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor.
Love RA; Parge HE; Wickersham JA; Hostomsky Z; Habuka N; Moomaw EW; Adachi T; Margosiak S; Dagostino E; Hostomska Z
Clin Diagn Virol; 1998 Jul; 10(2-3):151-6. PubMed ID: 9741640
[TBL] [Abstract][Full Text] [Related]
7. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
Tautz N; Kaiser A; Thiel HJ
Virology; 2000 Aug; 273(2):351-63. PubMed ID: 10915606
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease.
Zhu H; Briggs JM
Proteins; 2011 Aug; 79(8):2428-43. PubMed ID: 21633972
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.
Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B
Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919
[TBL] [Abstract][Full Text] [Related]
11. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.
Barbato G; Cicero DO; Nardi MC; Steinkühler C; Cortese R; De Francesco R; Bazzo R
J Mol Biol; 1999 Jun; 289(2):371-84. PubMed ID: 10366511
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.
Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B
Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610
[TBL] [Abstract][Full Text] [Related]
13. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins.
Massariol MJ; Zhao S; Marquis M; Thibeault D; White PW
Biochem Biophys Res Commun; 2010 Jan; 391(1):692-7. PubMed ID: 19944069
[TBL] [Abstract][Full Text] [Related]
14. Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide.
Urbani A; Biasiol G; Brunetti M; Volpari C; Di Marco S; Sollazzo M; Orrú S; Piaz FD; Casbarra A; Pucci P; Nardi C; Gallinari P; De Francesco R; Steinkühler C
Biochemistry; 1999 Apr; 38(16):5206-15. PubMed ID: 10213628
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors.
Geitmann M; Dahl G; Danielson UH
J Mol Recognit; 2011; 24(1):60-70. PubMed ID: 21194118
[TBL] [Abstract][Full Text] [Related]
16. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
[TBL] [Abstract][Full Text] [Related]
17. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
18. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.
Yan Y; Li Y; Munshi S; Sardana V; Cole JL; Sardana M; Steinkuehler C; Tomei L; De Francesco R; Kuo LC; Chen Z
Protein Sci; 1998 Apr; 7(4):837-47. PubMed ID: 9568891
[TBL] [Abstract][Full Text] [Related]
19. A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease.
Tomei L; Failla C; Vitale RL; Bianchi E; De Francesco R
J Gen Virol; 1996 May; 77 ( Pt 5)():1065-70. PubMed ID: 8609472
[TBL] [Abstract][Full Text] [Related]
20. An uniquely purified HCV NS3 protease and NS4A(21-34) peptide form a highly active serine protease complex in peptide hydrolysis.
Sardana VV; Blue JT; Zugay-Murphy J; Sardana MK; Kuo LC
Protein Expr Purif; 1999 Aug; 16(3):440-7. PubMed ID: 10425166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]